Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. Long Term Debt 2016–2025
Rhythm Pharmaceuticals Inc. annual long term debt history from 2023 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Rhythm Pharmaceuticals Inc. long term debt as of December 31, 2025: 100.9M, a 6.82% decrease year-over-year.
- Rhythm Pharmaceuticals Inc. long term debt for 2025 were 100.9M, a 6.82% decrease from 2024.
- Rhythm Pharmaceuticals Inc. long term debt for 2024 were 108.3M, a 2.00% increase from 2023.
- Rhythm Pharmaceuticals Inc. long term debt for 2023 were 106.1M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rhythm Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $101 |
| 2024 | $108 |
| 2023 | $106 |
Rhythm Pharmaceuticals Inc. Long Term Debt — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RYTM's long term debt history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.